Arbutus Biopharma Corporation Common Stock (ABUS)
Stock · NASDAQ · Health Care
$5.07as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$4.25
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $896.82M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Arbutus Biopharma Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 23, 2026 · via SEC EDGAR / Finnhub
Arbutus Biopharma Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- ABUSArbutus Biopharma Corporation Common Stock$5.07▼ 1.93%Market cap $896.82MP/E —
- ANNXAnnexon Inc. Common Stock$4.97▼ 5.33%Market cap $917.52MP/E —$2.03$7.18
- AMPHAmphastar Pharmaceuticals Inc. Common Stock$22.01▲ 0.59%Market cap $873.48MP/E 10.93$16.65$31.26
- DSGNDesign Therapeutics Inc. Common Stock$15.12▼ 0.85%Market cap $861.75MP/E —$5.04$17.25
- ACRSAclaris Therapeutics Inc. Common Stock$6.01▼ 2.44%Market cap $850.55MP/E —$1.74$6.6
- OMEROmeros Corporation Common Stock$18.59▼ 3.43%Market cap $951.74MP/E 14.37$3.94$19.65
- KURAKura Oncology Inc. Common Stock$12.65▼ 4.06%Market cap $823.83MP/E —$7.36$13.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corporation Common Stock | $896.82M | — | $5.07 | ▼ 1.93% | |
| ANNX Annexon Inc. Common Stock | $917.52M | — | $4.97 | ▼ 5.33% | $2.03$7.18 |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | $873.48M | 10.93 | $22.01 | ▲ 0.59% | $16.65$31.26 |
| DSGN Design Therapeutics Inc. Common Stock | $861.75M | — | $15.12 | ▼ 0.85% | $5.04$17.25 |
| ACRS Aclaris Therapeutics Inc. Common Stock | $850.55M | — | $6.01 | ▼ 2.44% | $1.74$6.6 |
| OMER Omeros Corporation Common Stock | $951.74M | 14.37 | $18.59 | ▼ 3.43% | $3.94$19.65 |
| KURA Kura Oncology Inc. Common Stock | $823.83M | — | $12.65 | ▼ 4.06% | $7.36$13.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- There are notable gap-ups and gap-downs in today's session.ChartMill · 8/21/2026
- Why Is Arbutus Biopharma Stock Gaining Friday?Benzinga · 8/21/2026
- Arbutus Biopharma Plans To Commence Modified Dutch Auction Tender Offer To Repurchase Up To $230M Of Common Shares At Purchase Price Of Between $5.00 And $5.75 Per Share In CashBenzinga · 8/21/2026
- Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K EstimateBenzinga · 8/12/2026
Insider Activity
Insider Actions →Acquired
157.6K
Disposed
0
- Sawhney Roger · June 8, 2026 · Grant78.8K
- Beardsley Robert A · June 8, 2026 · Grant78.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 137.23M
- Total value held
- $616.65M
- Institutional holders
- 163
Top holders this quarter
- Unknown25.89M
- Unknown18.56M
- Unknown14.93M
- Unknown12.97M
- Unknown6.69M
- Unknown6.63M
- Unknown6.34M
- Unknown4.32M
- Unknown3.77M
- Unknown3.13M
See the full, filterable feed with live charts on the MarketWall dashboard.